Literature DB >> 11673601

Pathogenic effect of an intermediate-size SCA-6 allele (CAG)(19) in a homozygous patient.

C Mariotti1, C Gellera, M Grisoli, R Mineri, A Castucci, S Di Donato.   

Abstract

SCA6 is caused by CAG expansion in the alpha 1A voltage-dependent calcium channel subunit gene. The authors studied an Italian family in which one patient carried a fully expanded SCA6 allele with 26-CAG repeats, whereas the other affected family member was homozygous for an intermediate-size allele of 19-CAG repeats. Three family members, heterozygous for the intermediate allele, were clinically unaffected. The findings demonstrate a dose-dependent pathogenic effect of an intermediate CAG expansion in the SCA6 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673601     DOI: 10.1212/wnl.57.8.1502

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

2.  Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.

Authors:  Kei Watase; Curtis F Barrett; Taisuke Miyazaki; Taro Ishiguro; Kinya Ishikawa; Yuanxin Hu; Toshinori Unno; Yaling Sun; Sayumi Kasai; Masahiko Watanabe; Christopher M Gomez; Hidehiro Mizusawa; Richard W Tsien; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

3.  A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6.

Authors:  Hiroki Takahashi; Kinya Ishikawa; Takeshi Tsutsumi; Hiroto Fujigasaki; Akihiro Kawata; Ryoichi Okiyama; Tsuneo Fujita; Kazuo Yoshizawa; Shigeki Yamaguchi; Hitoshi Tomiyasu; Fumihito Yoshii; Kazuko Mitani; Natsue Shimizu; Mineo Yamazaki; Tomoyuki Miyamoto; Tomoyuki Orimo; Shin'ichi Shoji; Ken Kitamura; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

4.  Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RET and SLC20A2.

Authors:  A Arteche-López; M I Álvarez-Mora; M T Sánchez Calvin; J M Lezana Rosales; C Palma Milla; M J Gómez Rodríguez; I Gomez Manjón; A Blázquez; A Juarez Rufián; P Ramos Gómez; O Sierra Tomillo; I Hidalgo Mayoral; R Pérez de la Fuente; I J Posada Rodríguez; L I González Granado; Miguel A Martin; J F Quesada-Espinosa; M Moreno-García
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 5.351

5.  Homozygous 31 trinucleotide repeats in the SCA2 allele are pathogenic for cerebellar ataxia.

Authors:  Maya Tojima; Gaku Murakami; Rie Hikawa; Hodaka Yamakado; Hirofumi Yamashita; Ryosuke Takahashi; Masaru Matsui
Journal:  Neurol Genet       Date:  2018-10-16

Review 6.  Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.

Authors:  Marianna Karwacka; Marta Olejniczak
Journal:  Cells       Date:  2022-02-02       Impact factor: 6.600

Review 7.  Autosomal dominant cerebellar ataxia type III: a review of the phenotypic and genotypic characteristics.

Authors:  Shinsuke Fujioka; Christina Sundal; Zbigniew K Wszolek
Journal:  Orphanet J Rare Dis       Date:  2013-01-18       Impact factor: 4.123

Review 8.  Molecular mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation.

Authors:  Paola Giunti; Elide Mantuano; Marina Frontali; Liana Veneziano
Journal:  Front Cell Neurosci       Date:  2015-02-16       Impact factor: 5.505

9.  The Pathogenic Role of Low Range Repeats in SCA17.

Authors:  Jung Hwan Shin; Hyeyoung Park; Gwan Hee Ehm; Woong Woo Lee; Ji Young Yun; Young Eun Kim; Jee-Young Lee; Han-Joon Kim; Jong-Min Kim; Beom Seok Jeon; Sung-Sup Park
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.